Your browser doesn't support javascript.
loading
RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A.
Chen, Dong-Bo; Xie, Xing-Wang; Zhao, Yang-Jing; Wang, Xue-Yan; Liao, Wei-Jia; Chen, Pu; Deng, Kang-Jian; Fei, Ran; Qin, Wan-Ying; Wang, Jiang-Hua; Wu, Xu; Shao, Qi-Xiang; Wei, Lai; Chen, Hong-Song.
Afiliação
  • Chen DB; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Disease, Beijing, 100044, China.
  • Xie XW; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Disease, Beijing, 100044, China.
  • Zhao YJ; Department of Immunology, and the Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, 212013, Jiangsu, China.
  • Wang XY; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Disease, Beijing, 100044, China.
  • Liao WJ; Laboratory of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, China.
  • Chen P; Laboratory of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, China.
  • Deng KJ; Laboratory of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, China.
  • Fei R; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Disease, Beijing, 100044, China.
  • Qin WY; Laboratory of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, China.
  • Wang JH; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Disease, Beijing, 100044, China.
  • Wu X; Center of Excellence, Becton Dickinson Biosciences, China Central Place, Beijing, 100176, China.
  • Shao QX; Department of Immunology, and the Key Laboratory of Laboratory Medicine of Jiangsu Province, School of Medicine, Jiangsu University, Zhenjiang, 212013, Jiangsu, China.
  • Wei L; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Disease, Beijing, 100044, China.
  • Chen HS; Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Disease, Beijing, 100044, China. chenhongsong@pkuph.edu.cn.
Sci Rep ; 10(1): 14538, 2020 09 03.
Article em En | MEDLINE | ID: mdl-32883983
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Histona Desmetilases com o Domínio Jumonji / Fatores de Transcrição de Fator Regulador X / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Histona Desmetilases com o Domínio Jumonji / Fatores de Transcrição de Fator Regulador X / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article